MedPath

Inhibitory Control and Eating Disorders

Completed
Conditions
Binge Eating
Anorexia Nervosa
Bulimia Nervosa
Registration Number
NCT03850288
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Executive functions are part of the high-level cognitive processes essential to the proper functioning of human cognition. They consist mainly of flexibility, updating and inhibition. Some studies have shown a correlation between executive disorders (impaired executive function) and psychiatric disorders such as obsessive-compulsive disorder or phobias. These executive disorders are related to dysfunctions of the fronto-striatal loops.

In addition, other studies have investigated the link that may exist between eating disorders such as anorexia or bulimia nervosa and executive functioning. Anorexia nervosa, bulimia nervosa and binge eating disorders are eating disorders characterized by a dysfunction in food intake with restriction of food or compulsions as well as strong concerns about the body schema. Concerning the executive functioning, these studies highlight a lack of cognitive flexibility for patients with anorexia nervosa and bulimia nervosa but also dysfunctions depending on the type of pathology (anorexia nervosa or bulimia nervosa). These studies also highlight the beneficial effects of cognitive remediation on people with eating disorders.

However, the investigation of the inhibitory control has not yet been specifically studied. Moreover, since eating disorders are structurally different, a comparison between several pathologies would be interesting to consider.

The aim of this study is to determine if a dysfunction of inhibitory control can be highlighted in people with eating disorders. This study would also allow further researches about cognitive remediation suitable for the specific difficulties encountered in these diseases.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
17
Inclusion Criteria
  • Woman aged 19 to 40 years old
  • Patient with a BMI between 13 and 40 kg/m2
  • Outpatients of the Refering Center of Eating Disorders ('Hospices Civils de Lyon' in Lyon) suffering of an eating disorder diagnosis (Anorexia Nervosa, Bulimia Nervosa or Binge Eating Disorder)
  • Patient who agrees to participate to the study.
Read More
Exclusion Criteria
  • Patient with psychiatric comorbidity severe (DSM V) and not stable (during the 8 weeks before inclusion)
  • Patient with psychotropic treatment (started or modified during the 8 weeks before inclusion)
  • Major patient protected by a measure of legal protection
  • Patient younger than 19 years old
  • Participation to another study at the same time
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Inhibition processes assessment - the Stroop task, Execution time1 day

Execution time in the Stroop task

Inhibition processes assessment - the Stroop task, Errors1 day

Errors in the Stroop task

Inhibition processes assessment - the Go No Go task, Execution time1 day

Execution time in the Go No Go task.

Inhibition processes assessment - the Go No Go task, Errors1 day

Errors in the Go No Go task

Inhibition processes assessment - the Go No Go task, Variability of execution time1 day

Variability of execution time in the Go No Go task

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre Référent pour l'Anorexie et les Troubles du Comportement Alimentaire

🇫🇷

Bron, France

© Copyright 2025. All Rights Reserved by MedPath